Pharmacokinetics of 3,3',5,5'-tetrachlorobiphenyl in the male rat
- PMID: 20292
Pharmacokinetics of 3,3',5,5'-tetrachlorobiphenyl in the male rat
Abstract
The pharmacokinetics of 3,3',5,5'-tetrachlorobiphenyl (4-CB) was studied to determine the importance of chlorine position to the kinetics of polychlorinated biphenyl (PCB) distribution, metabolism, and excretion by the rat. Tissue samples and excreta were collected at times ranging from 2 hr to 42 days after intravenous injection of a single 0.6-mg/kg dose of 14C-labeled 4-CB. The relative fractions of 4-CB and its metabolites were determined in selected samples, and 4-hr bile cannulations were performed to establish the rate of biliary excretion. A mathematical model description of PCB kinetics in the rat was defined here for 4-CB and used to generate tissue and excretion concentration-time profiles for both the parent compound and its metabolites. Model predictions were in good agreement with the experimental data, and showed how the individual pharmacokinetics of 4-CB compared to several other PBC's. The rate of 4-CB metabolism and excretion was slower than would be predicted according to its degree of chlorination. The relative rates of metabolism for 4-CB and five other differently chlorinated biphenyls could be ordered according to the number of adjacent unsubstituted carbon-atom pairs they contained. It appears that chlorine position is more important than degree of chlorination because the former can alter the availability of vicinal hydrogens thought to facilitate rapid PCB metabolism by mammals.
Similar articles
-
Effect of chlorination on the distribution and excretion of polychlorinated biphenyls.Drug Metab Dispos. 1975 Sep-Oct;3(5):371-80. Drug Metab Dispos. 1975. PMID: 241618
-
Use of a physiological compartmental model for the rat to describe the pharmacokinetics of several chlorinated biphenyls in the mouse.Drug Metab Dispos. 1980 Nov-Dec;8(6):397-403. Drug Metab Dispos. 1980. PMID: 6109607
-
A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat.Drug Metab Dispos. 1977 Jul-Aug;5(4):386-96. Drug Metab Dispos. 1977. PMID: 19218
-
The construction of a pharmacokinetic model for the disposition of polychlorinated biphenyls in the rat.Clin Pharmacol Ther. 1977 Nov;22(5 Pt 2):765-73. doi: 10.1002/cpt1977225part2765. Clin Pharmacol Ther. 1977. PMID: 410580 Review.
-
Pharmacokinetics of PCBs.Annu Rev Pharmacol Toxicol. 1984;24:85-103. doi: 10.1146/annurev.pa.24.040184.000505. Annu Rev Pharmacol Toxicol. 1984. PMID: 6428301 Review.
Cited by
-
Theoretical consideration of drug distribution kinetics in a noneliminating organ: comparison between a "homogeneous (well-stirred)" model and "nonhomogeneous (tube)" model.J Pharmacokinet Biopharm. 1985 Jun;13(3):265-87. doi: 10.1007/BF01065656. J Pharmacokinet Biopharm. 1985. PMID: 4087165
-
Physiologically based pharmacokinetic modeling of persistent organic pollutants for lifetime exposure assessment: a new tool in breast cancer epidemiologic studies.Environ Health Perspect. 2008 Jul;116(7):886-92. doi: 10.1289/ehp.10917. Environ Health Perspect. 2008. PMID: 18629310 Free PMC article.
-
Physiologically based pharmacokinetic models for anticancer drugs.Cancer Chemother Pharmacol. 1979;2(2):85-94. doi: 10.1007/BF00254079. Cancer Chemother Pharmacol. 1979. PMID: 93986 Review.
-
A pharmacokinetic model to differentiate preabsorptive, gut epithelial, and hepatic first-pass metabolism.J Pharmacokinet Biopharm. 1979 Aug;7(4):407-15. doi: 10.1007/BF01062538. J Pharmacokinet Biopharm. 1979. PMID: 512846